The treatment of tumors is important, as anyone in the field of brain cancer research can tell you. You want to be able to differentiate the healthy cells from those which are not nearly as healthy. Of course, this means that certain substances and tools will have to be put to use but which ones can prove themselves as the most effective, you may wonder? A certain drug came to my attention after reading a report and it seems to contain quite a bit of potential, too.
To say that brain cancer research is broad would be nothing short of an understatement. It is clear that there will be a number of approaches to consider and certain drugs will be put to use more so than others. Of course, those who understand this level of research will be able to tell you that surgery, in this regard, can prove to be quite risky. This is why new methods are going to be looked into, as organizations along the lines of Voices against Brain Cancer can tell you.
According to YottaFire, a drug by the name of J101 has been put to use by Cancer Research UK scientists but what is the function of this particular substance? Not only is it able to stop the growth and perpetuation of cancer cells but it is effective in leaving the healthy cells alone. It may seem hard to believe but the details are clear. What is it that helps to make J101 and what exactly allows the drug in question to go about this surprisingly effective process?
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
It's clear that this field is going to have a great deal of attention drawn to it, as many others will attest to. J101 is a drug that can work well for the purpose of differentiating between cells but it appears as though other drugs have come to the surface as well. Can these prove useful for some patients than they will for others? Whatever the case may be, the fact that they even exist means that the level of potential to be had is even greater.
To say that brain cancer research is broad would be nothing short of an understatement. It is clear that there will be a number of approaches to consider and certain drugs will be put to use more so than others. Of course, those who understand this level of research will be able to tell you that surgery, in this regard, can prove to be quite risky. This is why new methods are going to be looked into, as organizations along the lines of Voices against Brain Cancer can tell you.
According to YottaFire, a drug by the name of J101 has been put to use by Cancer Research UK scientists but what is the function of this particular substance? Not only is it able to stop the growth and perpetuation of cancer cells but it is effective in leaving the healthy cells alone. It may seem hard to believe but the details are clear. What is it that helps to make J101 and what exactly allows the drug in question to go about this surprisingly effective process?
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
It's clear that this field is going to have a great deal of attention drawn to it, as many others will attest to. J101 is a drug that can work well for the purpose of differentiating between cells but it appears as though other drugs have come to the surface as well. Can these prove useful for some patients than they will for others? Whatever the case may be, the fact that they even exist means that the level of potential to be had is even greater.
About the Author:
For more knowledge in regards to brain cancer research and awareness overall, kindly consult Voices against Brain Cancer
